Rebecca Clark, PhD, MSN, RN
Rebecca Clark, PhD, MSN, RN, a nurse scientist at Pennsylvania Hospital and an assistant professor in the School of Nursing at the University of Pennsylvania, has been named a fellow in the Betty Irene Moore Fellowship for Nurse Leaders and Innovatorsat the University of California, Davis. Clark is the first nurse scientist fellow from Penn in the program, which is designed to support early and mid-career leaders. Clark’s main fellowship project will involve the study of how reviewing video recordings of patient care can improve health outcomes for patients.
César de la Fuente, PhD
César de la Fuente, PhD, a Presidential Assistant Professor of Psychiatry, Microbiology, Chemical and Biomolecular Engineering, and Bioengineering, has been named a 2023-2026 National Academy of Medicine Emerging Leaders Scholar for his work on combining human and machine intelligence to accelerate scientific discovery and develop useful tools and life-saving medicines.
Mustafa Mir, PhD
Mustafa Mir, PhD, has been selected as one of Howard Hughes Medical Institute’s 31 new Freeman Hrabowski Scholars. The group consists of outstanding early career faculty in science who have potential to become leaders in their research fields and to create diverse and inclusive lab environments in which everyone can thrive. Mir and his lab develop and apply new microscopes to directly visualize the molecular scale events that underlie gene expression within live embryos.
Kim M. Olthoff, MD
Kim M. Olthoff, MD, chief of Transplant Surgery, has been awarded the 2023 Pioneer Award from the American Society of Transplant Surgeons (ASTS) on June 5 in San Diego, CA. The ASTS Pioneer Award is the most distinguished award bestowed by the ASTS to someone who has made significant contributions to the field of transplant. Olthoff's work focuses on liver regeneration and early allograft dysfunction in the transplant setting, genomics and genetics of transplantation, as well as advancing living liver donation. She is a trailblazer for women in transplant surgery, and served as the second woman president of the ASTS.
Wumush KC, MD, PhD, Edward Kreider, MD, PhD, and Elizabeth Traxler, MD, PhD
The Penn Measey Scholarsin Molecular Medicine Program has selected its first cohort of scholars. The program provides the most promising physician-scientist fellows pursing basic science training in Penn’s department of Medicine a strong foundation to launch an innovative independent program. The first scholars are: Wumush KC, MD, PhD, a Cardiovascular Disease fellow; Edward Kreider, MD, PhD, apostdoctoral fellow in the Weissman Lab; and Elizabeth Traxler, MD, PhD, a Hematology and Oncology fellow.
Penn Medicine is one of the world’s leading academic medical centers, dedicated to the related missions of medical education, biomedical research, excellence in patient care, and community service. The organization consists of the University of Pennsylvania Health System and Penn’s Raymond and Ruth Perelman School of Medicine, founded in 1765 as the nation’s first medical school.
The Perelman School of Medicine is consistently among the nation's top recipients of funding from the National Institutes of Health, with $550 million awarded in the 2022 fiscal year. Home to a proud history of “firsts” in medicine, Penn Medicine teams have pioneered discoveries and innovations that have shaped modern medicine, including recent breakthroughs such as CAR T cell therapy for cancer and the mRNA technology used in COVID-19 vaccines.
The University of Pennsylvania Health System’s patient care facilities stretch from the Susquehanna River in Pennsylvania to the New Jersey shore. These include the Hospital of the University of Pennsylvania, Penn Presbyterian Medical Center, Chester County Hospital, Lancaster General Health, Penn Medicine Princeton Health, and Pennsylvania Hospital—the nation’s first hospital, founded in 1751. Additional facilities and enterprises include Good Shepherd Penn Partners, Penn Medicine at Home, Lancaster Behavioral Health Hospital, and Princeton House Behavioral Health, among others.
Penn Medicine is an $11.1 billion enterprise powered by more than 49,000 talented faculty and staff.